Bridgebio Pharma shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Bridgebio Pharma
Tip: Access up to 7 years of quarterly data
All positions including Bridgebio Pharma held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Bridgebio Pharma by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $27M | 513k | 51.94 |
| 2025-06-30 | $30M | 704k | 43.18 |
| 2025-03-31 | $21M | 605k | 34.57 |
| 2024-12-31 | $17M | 610k | 27.44 |
| 2024-09-30 | $17M | 660k | 25.46 |
| 2024-06-30 | $18M | 706k | 25.33 |
| 2024-03-31 | $20M | 642k | 30.92 |
| 2023-12-31 | $27M | 660k | 40.37 |
| 2023-09-30 | $18M | 696k | 26.37 |
| 2023-06-30 | $12M | 705k | 16.58 |
| 2023-03-31 | $12M | 705k | 16.58 |
| 2022-12-31 | $792k | 104k | 7.62 |
| 2022-09-30 | $1.1M | 108k | 9.94 |
| 2022-06-30 | $769k | 85k | 9.08 |
| 2022-03-31 | $664k | 66k | 10.15 |
| 2021-12-31 | $1.1M | 65k | 16.68 |
| 2021-09-30 | $3.3M | 71k | 46.87 |
| 2021-06-30 | $4.2M | 69k | 60.96 |
| 2021-03-31 | $2.4M | 39k | 61.60 |
| 2020-12-31 | $6.5M | 174k | 37.52 |
| 2020-09-30 | $6.5M | 174k | 37.52 |
| 2020-06-30 | $5.8M | 177k | 32.61 |
| 2020-03-31 | $4.9M | 169k | 29.00 |
| 2019-12-31 | $2.7M | 77k | 35.05 |
| 2019-09-30 | $1.7M | 77k | 21.47 |
| 2019-06-30 | $2.0M | 75k | 26.97 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas